Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage.

Yolanda Silva Blas,Michael N. Diringer,Benjamin Lo,Jaime Masjuan,Natalia Pérez de la Ossa,Cardinal Matthew H,Florence H. Yong,Tong Zhu,Gang Li,Steven Arkin

Phase 1b Study to Evaluate Safety, Tolerability, and Maximum Tolerated Dose of PF-05230907 for Intracerebral Hemorrhage.

2020

Yolanda Silva Blas
Michael N. Diringer
Benjamin Lo
Jaime Masjuan
Natalia Pérez de la Ossa
Cardinal Matthew H
Florence H. Yong
Tong Zhu
Gang Li
Steven Arkin

Background and Purpose: This study aimed to determine the maximum tolerated dose and to evaluate the overall safety and tolerability of single doses of PF-05230907 in subjects with acute intracereb...

Keywords:

safety tolerability
Intracerebral hemorrhage
Tolerability
Maximum tolerated dose
Thrombosis
Anesthesia
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations